Ernexa Therapeutics Inc. Warrants (ERNAW) Stock Price
ERNAWStock
$0.05
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta—
ERNAW Share Price Chart
Favorite Metrics
Price vs S&P 500 (4W)7.15%
VGM Score89.15
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ERNAWErnexa Therapeutics Inc. Warrants | — | — | A | $0.05 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Ernexa Therapeutics Inc. Warrants
Ernexa Therapeutics develops cell-based medicines for cancer and autoimmune diseases using proprietary technology that transforms iPSCs into iMSCs. The platform generates off-the-shelf treatment solutions without patient-specific cell harvesting, potentially offering advantages in scalability and manufacturing efficiency.